Intrinsiqq
CVRx, Inc. logo

CVRx, Inc. Quality Score

CVRX

⊜ Compare
Quality40

Valuation is the primary weakness (avg 0/100). No single area scores well.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-0.8x

Negative earnings, no valuation support

Cash Flow Multiple
0/100
-1.0x

Negative FCF, no valuation support

Revenue Growth
100/100
28.5%

Above 10% CAGR, strong compounder

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
0/100
29.1%

Heavy dilution above 5%

Margin Trend
100/100
+109.8pp

Expanded 3+pp, strong improvement

Capital Structure
100/100
-$5M

Net cash position, no leverage concern

2022
$106M
$7.00M
2023
$91.0M
$31.0M
2024
$106M
$50.0M
2025
$76.0M
$51.0M
TTM
$65.0M
$59.0M
CashDebt
Return on Capital
0/100
-43.1%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

CVRx (CVRX) quality: score, margins and returns

CVRx (CVRX) scores 40/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 6 metrics each scored 0 to 100, on -79.5% operating margins and -43.1% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is CVRx (CVRX) a high-quality business?+

CVRx scores 40 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a -79.5% operating margin and a -43.1% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does CVRx's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from CVRX's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where CVRx scores well and where it falls behind.

What is CVRx's return on invested capital (ROIC)?+

CVRx earns about -43.1% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to CVRX's margins and growth on this scorecard to judge durability.

How profitable is CVRx?+

CVRx runs an operating margin of about -79.5% and a net margin of about -84.9%. Revenue has grown at roughly 56.4% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 30 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 18 Sept 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with CVRX

CompareIntrinsic value
LNSRLensar Inc.
$5.84+4.85%40
SIShoulder Innovations, Inc.
$21.01+6.00%35
CARLCarlsmed, Inc.
$16.09+11.74%44
VEROVenus Concept Inc.
No recent price10
APYXApyx Medical Corporation
$2.59-0.38%26
SSIISS Innovations International, Inc.
$2.27-2.58%40
RCELAvita Medical Inc.
$16.32+6.46%30
KRMDKoru Medical Systems Inc.
$3.27+5.48%55

Spot a number that looks wrong? Check it in CVRX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CVRX

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.